Author

Rami Hourani

Stanford University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Alok RanjaniD· 1 shared Anjie ZheniD· 1 shared Brian H. YuiD· 1 shared Jose A. MoraniD· 1 shared Matthew D. MarsdeniD· 1 shared Nishad S. MaggirwariD· 1 shared Paul A. WenderiD· 1 shared Shireen R. Turner· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alok RanjanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Leveraging HIV-Specific CAR T Cells and Rapamycin Treatment in Kick-and-Kill HIV Cure Approaches

Nishad S. Maggirwar, Jose A. Moran, Wenli Mu, Thomas D. Zaikos, Tessa C. Chou, Shireen R. Turner, Brian H. Yu, Alok Ranjan, Rami Hourani, Paul A. Wender, Anjie Zhen, Matthew D. Marsden

This paper demonstrates that combining HIV-specific CAR T cells with rapamycin and latency reversing agents can reduce immune exhaustion and effectively target HIV-infected cells.

bioRxiv · Jan 15, 2026 · PreprintImmunology